Detalles de la búsqueda
1.
Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools.
Value Health
; 25(10): 1760-1767, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35595634
2.
Value assessment of oncology drugs using a weighted criterion-based approach.
Cancer
; 126(7): 1530-1540, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31860138
3.
Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016.
J Med Econ
; 23(12): 1558-1569, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33161782
4.
The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need.
J Health Econ Outcomes Res
; 3(1): 13-23, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430665
5.
Bias within economic evaluations - the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug.
Clinicoecon Outcomes Res
; 7: 497-503, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26504402
6.
The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels.
Can J Clin Pharmacol
; 10(3): 101-6, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-14506507
7.
An economic evaluation of voriconazole versus amphotericin B for the treatment of invasive aspergillosis in Canada.
Can J Infect Dis Med Microbiol
; 15(5): 277-84, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18159506
8.
Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.
Can J Cardiol
; 24(4): 269-73, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18401466
Resultados
1 -
8
de 8
1
Próxima >
>>